Drug Profile
Gallium-67 DOTA MIL 38 monoclonal antibody - Minomic International
Alternative Names: MIL 38/Gallium 67; MILGa; MiltuximabLatest Information Update: 28 Mar 2020
Price :
$50
*
At a glance
- Originator Minomic International
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies; Radiopharmaceutical diagnostics
- Mechanism of Action Single-photon emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bladder cancer; Pancreatic cancer; Prostate cancer
Most Recent Events
- 28 Mar 2020 No recent reports of development identified for clinical-Phase-Unknown development in Bladder-cancer(Diagnosis) in Australia (IV, Infusion)
- 28 Mar 2020 No recent reports of development identified for clinical-Phase-Unknown development in Prostate-cancer(Diagnosis) in Australia (IV, Infusion)
- 28 Feb 2020 No recent reports of development identified for clinical-Phase-Unknown development in Pancreatic-cancer(Diagnosis) in Australia (IV, Infusion)